AI assistant
BIO-TECHNE Corp — Director's Dealing 2019
May 2, 2019
30718_dirs_2019-05-02_a74bb852-835d-40a2-8b35-85f1978546df.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2019-05-01
Reporting Person: Hippel James (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-05-01 | Common Stock | M | 35000.00 | $86.25 | Acquired | 39382.00 | Direct |
| 2019-05-01 | Common Stock | S | 35000.00 | $203.0766 | Disposed | 4382.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-01 | Stock Options (Right to buy) | $86.25 | M | 10000.00 | Acquired | 2021-04-01 | Common Stock (10000.00) | Direct |
| 2019-05-01 | Stock Options (Right to buy) | $86.25 | M | 25000.00 | Acquired | 2021-04-01 | Common Stock (25000.00) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Units | $ | Common Stock (3383.00) | 3383.00 | Direct | |
| Restricted Stock Units | $ | Common Stock (4438.00) | 4438.00 | Direct | |
| Restricted Stock Units | $ | Common Stock (4925.00) | 4925.00 | Direct | |
| Stock Option (Right to Buy) | $106.59 | 2023-08-18 | Common Stock (30400.00) | 30400.00 | Direct |
| Stock Option (Right to Buy) | $94.35 | 2021-08-12 | Common Stock (35000.00) | 35000.00 | Direct |
| Stock Options (Right to buy) | $177.32 | 2025-08-08 | Common Stock (24089.00) | 24089.00 | Direct |
| Stock Options (Right to buy) | $177.32 | 2025-08-08 | Common Stock (18066.00) | 18066.00 | Direct |
| Stock Options (Right to buy) | $125.05 | 2024-08-09 | Common Stock (24460.00) | 24460.00 | Direct |
| Stock Options (Right to buy) | $125.05 | 2024-08-09 | Common Stock (32613.00) | 32613.00 | Direct |
| Stock Options (Right to buy) | $108.49 | 2022-08-07 | Common Stock (25000.00) | 25000.00 | Direct |
| Stock Options (Right to buy) | $106.59 | 2023-08-18 | Common Stock (40533.00) | 40533.00 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.28 to $205.38, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
F3: Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F4: Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F5: Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator)
F6: Vests in full or in part on 8/18/19 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7: 8,750 shares vest on each of 8/12/15, 8/12/16, 8/12/17 and 8/12/18.
F8: Vests 6,023 shares on 8/8/2019 and 6,022 shares each on 8/8/2020, 8/8/2021 and 8/8/20202
F9: Vests 8,153 shares each on 8/19/2018, 8/9/2019, 8/9/2020 and 8,154 on 8/9/2021
F10: 6,250 shares vest on each of 8/7/16, 8/7/17, 8/7/18 and 8/7/19.
F11: Vests 10,134 shares on 8/18/17, and 10,133 shares on each of 8/18/18, 8/18/19 and 8/18/20.